Physician profile
Asma Naeem
NPI 1912956442
$7,956.21
in general payments reported to CMS, 2019-2025
50 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $350 · 2021: $1,022 · 2022: $1,280 · 2023: $1,510 · 2024: $1,892 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,780 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,780.10 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,387.39 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $769.80 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Novartis Pharmaceuticals Corporation | $487.56 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $355.92 | 2023-2025 | Rexulti, Abilify Maintena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.65 | 2019-2023 | Spiriva Respimat, Stiolto Respimat |
| Astellas Pharma US INC | $329.52 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $318.55 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $313.67 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $268.07 | 2019-2024 | Breztri, Farxiga |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $245.12 | 2023-2025 | Caplyta |
| Genzyme Corporation | $243.03 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $223.45 | 2021-2023 | Dificid |
| Pfizer INC. | $185.48 | 2019-2025 | |
| Amgen INC. | $173.97 | 2022-2025 | Otezla, Repatha, Repatha |
| Allergan, INC. | $168.99 | 2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $164.27 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Dexcom, INC. | $153.92 | 2021-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $153.76 | 2022-2025 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $145.51 | 2024 | |
| Amarin Pharma, INC. | $141.67 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $130.86 | 2025 | Gemtesa |
| Lundbeck LLC | $108.93 | 2024-2025 | Rexulti |
| Baxter Healthcare | $108.10 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Medline Industries LP | $98.59 | 2024 | |
| Abbott Laboratories | $91.63 | 2021-2024 | Freestyle Libre 3 |
| Ironwood Pharmaceuticals, INC | $81.39 | 2023-2025 | Linzess |
| Irhythm Technologies, INC. | $78.11 | 2024 | Zio Monitor, Zio Xt Patch |
| Ardelyx, INC. | $71.67 | 2023-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $64.64 | 2024-2025 | Voquezna |
| Paratek Pharmaceuticals, INC. | $64.56 | 2021-2022 | |
| Hologic Sales and Service, LLC | $56.96 | 2022-2023 | Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $39.50 | 2022 | |
| Azurity Pharmaceuticals, INC. | $38.44 | 2023 | Edarbi, Adthyza |
| Kowa Pharmaceuticals America, INC. | $32.86 | 2019-2025 | Zoryve |
| Seqirus USA INC | $29.35 | 2024 | Fluad, Flucelvax |
| Axsome Therapeutics, INC. | $29.06 | 2025 | Symbravo |
| Sanofi-Aventis U.S. LLC | $25.68 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.45 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $23.08 | 2021 | |
| Mylan Specialty L.P. | $22.79 | 2023 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $22.63 | 2022 | |
| Alk-Abello, INC | $20.93 | 2024 | Grastek, Ragwitek, Odactra |
| Idorsia Pharmaceuticals US INC | $20.42 | 2023 | Quviviq |
| Scilex Pharmaceuticals INC. | $19.49 | 2025 | |
| Shield Therapeutics INC | $19.45 | 2023 | Accrufer |
| Hikma Pharmaceuticals USA | $18.52 | 2021 | |
| Currax Pharmaceuticals LLC | $17.26 | 2025 | Contrave |
| Phadia US INC. | $12.99 | 2023 | Immunocap |
| Horizon Therapeutics Plc | $11.84 | 2021 | |
| Genentech USA, INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asma Naeem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.